Autolus Therapeutics plc (AUTL) Operating cash flow 2016–2025
Autolus Therapeutics plc (AUTL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$283.6MFY2025 · since FY2016: -$9.8M → -$283.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$283.6M | -37.5% |
| FY2024 | -$206.3M | -41.7% |
| FY2023 | -$145.6M | -29.6% |
| FY2022 | -$112.3M | +4.7% |
| FY2021 | -$117.9M | -0.1% |
| FY2020 | -$117.8M | -16.0% |
| FY2019 | -$101.5M | -221.8% |
| FY2018 | -$31.5M | -92.8% |
| FY2017 | -$16.4M | -66.1% |
| FY2016 | -$9.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AUTL financial trends
AUTL RevenueAUTL Net incomeAUTL Net marginAUTL Gross profitAUTL Gross marginAUTL Operating incomeAUTL Operating marginAUTL Free cash flowAUTL Capital expendituresAUTL Return on equityAUTL Stock buybacksAUTL Dividends paidAUTL Total assetsAUTL Total liabilitiesAUTL Shareholders’ equityAUTL overview →